BIOMAT Database Logo BIOMAT Database Logo

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. 2010

Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Department of Medical Biology and Genetics, Human Gene and Cell Therapy Center of Akdeniz University Hospitals and Clinics, Antalya 07058, Turkiye.

BACKGROUND Lung cancer causes the highest rate of cancer-related deaths both in men and women. As many current treatment modalities are inadequate in increasing patient survival, new therapeutic strategies are required. TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in tumor cells but not in normal cells, prompting its current evaluation in a number of clinical trials. The successful therapeutic employment of TRAIL is restricted by the fact that many tumor cells are resistant to TRAIL. The goal of the present study was to test a novel combinatorial gene therapy modality involving adenoviral delivery of TRAIL (Ad5hTRAIL) and IKK inhibition (AdIKKβKA) to overcome TRAIL resistance in lung cancer cells. METHODS Fluorescent microscopy and flow cytometry were used to detect optimum doses of adenovirus vectors to transduce lung cancer cells. Cell viability was assessed via a live/dead cell viability assay. Luciferase assays were employed to monitor cellular NF-κB activity. Apoptosis was confirmed using Annexin V binding. RESULTS Neither Ad5hTRAIL nor AdIKKβKA infection alone induced apoptosis in A549 lung cancer cells, but the combined use of Ad5hTRAIL and AdIKKβKA significantly increased the amount of A549 apoptosis. Luciferase assays demonstrated that both endogenous and TRAIL-induced NF-κB activity was down-regulated by AdIKKβKA expression. CONCLUSIONS Combination treatment with Ad5hTRAIL and AdIKKβKA induced significant apoptosis of TRAIL-resistant A549 cells, suggesting that dual gene therapy strategy involving exogenous TRAIL gene expression with concurrent IKK inhibition may be a promising novel gene therapy modality to treat lung cancer.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB

Related Publications

Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
January 2015, Cell biochemistry and biophysics,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling.
September 2018, Life sciences,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
December 2015, Oncotarget,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
EGCG sensitizes human nasopharyngeal carcinoma cells to TRAIL-mediated apoptosis by activation NF-κB.
January 2017, Neoplasma,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.
September 2007, Cell cycle (Georgetown, Tex.),
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Targeting IKK and NF-κB for Therapy.
January 2017, Advances in protein chemistry and structural biology,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
December 2002, Experimental & molecular medicine,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Using RNA interference in lung cancer cells to target the IKK-NF-κB pathway.
January 2015, Methods in molecular biology (Clifton, N.J.),
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Simultaneous inhibition of Rac1 and IKK pathways sensitizes lung cancer cells to TNFalpha-mediated apoptosis.
November 2001, Cancer gene therapy,
Cigdem Aydin, and Ahter D Sanlioglu, and Atil Bisgin, and Burcak Yoldas, and Levent Dertsiz, and Bahri Karacay, and Thomas S Griffith, and Salih Sanlioglu
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation.
August 2017, Cancer biology & medicine,
Copied contents to your clipboard!